Equities

MicroTech Medical (Hangzhou) Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

MicroTech Medical (Hangzhou) Co Ltd

Actions
  • Price (HKD)7.34
  • Today's Change0.07 / 0.96%
  • Shares traded5.90k
  • 1 Year change+47.39%
  • Beta0.6251
Data delayed at least 15 minutes, as of Feb 16 2026 02:40 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

MicroTech Medical (Hangzhou) Co Ltd is a China-based company primarily engaged in the research and development, manufacturing and sale of medical devices. The Company's main business is engaged in the manufacture and sale of blood glucose monitoring system (BGMS), continuous glucose monitoring system (CGMS) and insulin pump systems. The Company has the portfolio of products in the field of diabetes monitoring, treatment and management, covering patch insulin pump system, CGMS, closed-loop artificial pancreas system, BGMS products, as well as diabetes digital management software. The Company conducts its businesses in the domestic and overseas markets.

  • Revenue in HKD (TTM)498.61m
  • Net income in HKD-31.31m
  • Incorporated2011
  • Employees645.00
  • Location
    MicroTech Medical (Hangzhou) Co LtdNo. 108 Liuze StreetCangqian Street, Yuhang DistrictHANGZHOU ChinaCHN
  • Websitehttps://www.microtechmd.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.